ARCHIVES

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

December 2, 1983

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

Nomograms 66% Correct In Predicting Outcome For Brachytherapy, Study Finds

September 28, 2001

Includes January Business & Regulatory Report (8-page issue).

January 31, 2003

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010